Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways

Overview of attention for article published in Frontiers in Pharmacology, August 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 5 X posts from 2 X users, with an upper bound of 6,550 followers.

Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways https://t.co/YTCoRxhRlD

Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways https://t.co/YTCoRxhRlD

Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways https://t.co/YTCoRxhRlD

Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways https://t.co/YTCoRxhRlD

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.